NCI advisors approve recompetition of $62 million phase II contracts program.
Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.
Advisors approve set-aside for alternative medicine “best case series.”
HHS bans tobacco from its campuses, opens national quitline, 1-800-QUITNOW.
Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.
Funding opportunities listed.
November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.
Trending Stories
- CBER Director Vinay Prasad sidelined staff to jettison Moderna’s mRNA flu shot
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades ago
Lowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.” - Team USA’s Julie Letai competes in Milan Olympics speed skating event
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Lowy fields questions about peer review at inaugural meeting of the new NCAB ad hoc working group









